Evidence map›Paper›PMID 41803809›Full record

ArticleMicrobial cell factories2026

Efficient production of glycine from glucose via a two-stage biosynthetic strategy.

Lei Chen, Zhijie Zheng, Feifei Chen, Weipeng Wang, Siqi Huo, Xiangyu Li, Alei Zhang, Kequan Chen

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei ChenState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Zhijie ZhengState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Feifei ChenState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Weipeng WangCABIO Biotech Co., Ltd, Wuhan, China.
Siqi HuoState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Xiangyu LiCABIO Biotech Co., Ltd, Wuhan, China. neal_lee@cabio.cn.
Alei ZhangState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China. zhangalei@njtech.edu.cn.
Kequan ChenState Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China. kqchen@njtech.edu.cn.

Funding

Jiangsu Association for Science and Technology Young Scientific and Technological Talents Support Project JSTJ-2024-278Jiangsu Basic Research Center for Synthetic Biology BK20233003National Key R&D Program of China 2021YFA0911400National Natural Science Foundation of China 22278220 and U21B2097Young Elite Scientist Sponsorship Program by CAST 2024QNRC368
6 · The paper itself

Abstract

backgroundHigh-quality glycine is widely used in the cosmetics and pharmaceutical industries. Conventional chemical synthesis of glycine is disfavored because it relies on toxic reagents and complex downstream purification.

resultsHerein, we established an efficient two-step biosynthetic process for producing glycine from glucose. First, an L-threonine−overproducing strain was used to synthesis L-threonine via 50 L fed-batch fermentation, achieving a titer of 119.3 g/L. Then, a highly active L-threonine aldolase (PpLTA) was screened to convert L-threonine into glycine. To overcome thermodynamic and acetaldehyde inhibition constraints, an acetaldehyde elimination system was constructed via introducing ScADH1 and ScCR, which increased the molar conversion yield of glycine increased by 3.9-fold. Whole-cell catalysis gave a significantly higher conversion yield than crude enzyme preparations. A whole-cell co-expressing PpLTA, ScADH1, and ScCR was subsequently constructed. Finally, at 50 L scale, direct conversion of L-threonine fermentation broth afforded a glycine titer of 65.4 g/L within 24 h, with a molar conversion yield of 87.2%, In addition, 99.8% pure glycine was obtained with a yield of 76.6% via separation.

conclusionsAn efficient two-step process for converting glucose to glycine was developed and successfully validated. Evaluation at the 50 L scale demonstrated record-high glycine production performance. This work provides a promising technological route for the industrial manufacture of high-quality glycine.

Indexed as

GlucoseGlycineEscherichia coliFermentationThreonineGlucoseGlycineThreonineAcetaldehyde eliminationHigh-quality glycinel-threonine fermentationTwo step biosynthesisWhole cell catalysis

Identifiers

PMID41803809
PMCPMC13104294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.